These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 6601656

  • 1. Cefotetan: profile of in-vitro activity.
    Bauernfeind A.
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F, Flournoy DJ, Qadri SM.
    Chemotherapy; 1983 Jan; 29(1):37-42. PubMed ID: 6219865
    [Abstract] [Full Text] [Related]

  • 7. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW, Jones RN, Barry AL, Thornsberry C, Fuchs PC, Gavan TL, Gerlach EH, Sommers HM.
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cefotetan: antimicrobial activity in-vitro compared with that of cefotaxime.
    Dette GA, Knothe H, Henckel S.
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():11-7. PubMed ID: 6302064
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Phillips I, King A, Shannon K, Warren C.
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():1-9. PubMed ID: 6601650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
    Neu HC, Chin NX, Labthavikul P.
    Chemioterapia; 1985 Dec; 4(6):415-23. PubMed ID: 3879464
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC, Chin NX, Neu NM.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [Abstract] [Full Text] [Related]

  • 17. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
    Raimondi A, Mattina R, Cocuzza CE.
    Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
    [Abstract] [Full Text] [Related]

  • 18. In vitro combination effects of cefotetan with four aminoglycosides, piperacillin and mezlocillin on gram-positive and gram-negative nosocomial bacteria.
    Just HM, Becker C, Bassler M, Daschner FD.
    Chemotherapy; 1984 Feb; 30(6):387-91. PubMed ID: 6596165
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN, Wilson HW.
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.